Y Intercept (Hong Kong) LTD Ptc Therapeutics, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 11,024 shares of PTCT stock, worth $581,626. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,024
Previous 13,829
20.28%
Holding current value
$581,626
Previous $513,000
3.12%
% of portfolio
0.03%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding PTCT
# of Institutions
258Shares Held
77.4MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$484 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$410 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$390 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$337 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$253 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.77B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...